ADMINISTRATION DE MEDICAMENT CIBLEE SUR L'HEMOGLOBINE POUR LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

THERAPURE BIOPHARMA INC.

发明人:

BROOKES, STEVEN,ADAMSON, J. GORDON,BELL, DAVID

申请号：

CA3028589

公开号：

CA3028589A1

申请日:

2017.06.21

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The use of hemoglobin as a targeting carrier for drugs is disclosed. Such hemoglobin-drug complexes have utility in the treatment of cancer, in particular cancers of the liver and colon. Said drug is preferably a nucleoside analog, in particular floxuridine and is covalently attached to the hemoglobin in a molar drug ratio of between 1 and 20.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/